References
- Repka MA, McGinity JW, Zhang F, Koleng JJ. (2002). Hot melt extrusion technology. In: Swarbrick J, Boylan J, eds. Encyclopedia of Pharmaceutical Technology. Second edition. New York, NY: Marcel Dekker, 203–266.
- Breitenbach J. (2002). Melt extrusion: from process to drug delivery technology. Eur j Pharm Biopharm, 54:107–117.
- Forster A, Hempenstall J, Tucker I, RadesT. (2001). Selection of excipients for melt extrusion with two poorly soluble drugs by solubility parameter calculation and thermal analysis. Int J Pharm 226, 147–161.
- Hülsman S, Backensfeld T, Keitel S, Bodmeier R. (2000). Melt extrusion an alternative method for enhancing the dissolution rate of 17 B-estradiol hemihydrate. Eur J Pharm Biopharm 49, 237–242.
- Crowley MM, Zhang F, Repka MA, Thumma S, Upadhye SB, Battu SK, McGinity JW, Martin C. (2007). Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm 33, 909–926.
- Miller-Chou BA, Koening JL. (2003). A review of polymer dissolution. Prog Polym Sci 28, 1223–1270.
- Perissutti B, Newton JM, Podczeck F, Rubessa F. (2002). Preparation of extruded carbamazepine and PEG 4000 as a potential rapid release dosage form. Eur j Pharm Biopharm, 53:125–132.
- He H, Yang R, Tang X. (2010). In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion. Drug Dev Ind Pharm 36, 681–687.
- Coleman MM, Painter PC. (2006). Miscible Polymer Blends: Background and Guide for Calculations and Design. Lancaster, PA: Destech Pubns Inc.
- Lloyd R, Craig DQM, Smith A. (1997). An investigation into the melting behaviour of binary mixes and solid dispersions of paracetamol and PEG 4000. J Pharm Sci 86, 991–996.
- Miller DA, McConville JT, Yang W, Williams RO, McGinity JW. (2007). Hot-melt extrusion for enhanced delivery of drug particles. J Pharm Sci 96, 361–376.
- Connors RD, Elder EJ. Solubilization solutions “on line”. http://www.drugdeliverytech.com issue date; vol.4 Nº8 October 2004
- Greenhalgh DJ, Williams AC, Timmins P, York P. (1999). Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci, 88:1182–1190.
- Zheng X, Yang R, Zhang Y, Wang Z, Tang X, Zheng L. (2007a). Part I characterisation of solid dispersions of Nimodipine prepared by hot melt extrusion. Drug Dev Ind Pham 33, 791–802.
- Leuner C, Dressman J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm, 50:47–60.
- Wang L, Cui FD, Hayase T, Sunada H. (2005). Preparation and evaluation of solid dispersion for nitrendipine-carbopol and nitrendipine-HPMCP systems using a twin screw extruder. Chem Pharm Bull, 53:1240–1245.
- Rambali B, Verreck G, Baert L, Massart DL. (2003). Itraconazole formulation studies of melt extrusion process with mixture design. Drug Dev Ind Pharm 29, 641–652.
- Bailer A. (1988). John Testing for the equality of area under the curves when using destructive measurement techniques. J Pharmacokin Biopharm 16, 303–309.
- Zheng X, Yang R, Zhang Y, Wang Z, Tang X, Zheng L. (2007b). Bioavailability in beagle dogs of Nimodipine solid dispersions prepared by hot-melt extrusion. Drug Dev Ind Pharm 33, 783–789.